24-Week beta-alanine ingestion does not affect muscle taurine or clinical blood parameters in healthy males

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorSAUNDERS, Bryan
dc.contributor.authorFRANCHI, Mariana
dc.contributor.authorOLIVEIRA, Luana Farias de
dc.contributor.authorSILVA, Vinicius da Eira
dc.contributor.authorSILVA, Rafael Pires da
dc.contributor.authorPAINELLI, Vitor de Salles
dc.contributor.authorCOSTA, Luiz Augusto Riani
dc.contributor.authorSALE, Craig
dc.contributor.authorHARRIS, Roger Charles
dc.contributor.authorROSCHEL, Hamilton
dc.contributor.authorARTIOLI, Guilherme Giannini
dc.contributor.authorGUALANO, Bruno
dc.date.accessioned2020-03-24T14:52:54Z
dc.date.available2020-03-24T14:52:54Z
dc.date.issued2020
dc.description.abstractPurpose To investigate the effects of chronic beta-alanine (BA) supplementation on muscle taurine content, blood clinical markers and sensory side-effects. Methods Twenty-five healthy male participants (age 27 +/- 4 years, height 1.75 +/- 0.09 m, body mass 78.9 +/- 11.7 kg) were supplemented with 6.4 g day(-1) of sustained-release BA (N = 16; CarnoSyn (TM), NAI, USA) or placebo (PL; N = 9; maltodextrin) for 24 weeks. Resting muscle biopsies of the m. vastus lateralis were taken at 0, 12 and 24 weeks and analysed for taurine content (BA, N = 12; PL, N = 6) using high-performance liquid chromatography. Resting venous blood samples were taken every 4 weeks and analysed for markers of renal, hepatic and muscle function (BA, N = 15; PL, N = 8; aspartate transaminase; alanine aminotransferase; alkaline phosphatase; lactate dehydrogenase; albumin; globulin; creatinine; estimated glomerular filtration rate and creatine kinase). Results There was a significant main effect of group (p = 0.04) on muscle taurine, with overall lower values in PL, although there was no main effect of time or interaction effect (both p > 0.05) and no differences between specific timepoints (week 0, BA: 33.67 +/- 8.18 mmol kg(-1) dm, PL: 27.75 +/- 4.86 mmol kg(-1) dm; week 12, BA: 35.93 +/- 8.79 mmol kg(-1) dm, PL: 27.67 +/- 4.75 mmol kg(-1) dm; week 24, BA: 35.42 +/- 6.16 mmol kg(-1) dm, PL: 31.99 +/- 5.60 mmol kg(-1) dm). There was no effect of treatment, time or any interaction effects on any blood marker (all p > 0.05) and no self-reported side-effects in these participants throughout the study. Conclusions The current study showed that 24 weeks of BA supplementation at 6.4 g day(-1) did not significantly affect muscle taurine content, clinical markers of renal, hepatic and muscle function, nor did it result in chronic sensory side-effects, in healthy individuals. Since athletes are likely to engage in chronic supplementation, these data provide important evidence to suggest that supplementation with BA at these doses for up to 24 weeks is safe for healthy individuals.eng
dc.description.indexMEDLINEeng
dc.description.sponsorshipFundacao de Amparo a Pesquisa do Estado de Sao PauloFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2016/50438-0, 2017/04973-4, 2015/22686-7, 2013/04806-0, 2012/13026-5, 2014/11948-8, 2013/14746-4]
dc.description.sponsorshipCoordenacao de Aper-feicoamento de Pessoal de Nivel Superior-Brasil (CAPES) [001]
dc.description.sponsorshipNational Alternatives International (NAI), San Marcos, California
dc.identifier.citationEUROPEAN JOURNAL OF NUTRITION, v.59, n.1, p.57-65, 2020
dc.identifier.doi10.1007/s00394-018-1881-0
dc.identifier.eissn1436-6215
dc.identifier.issn1436-6207
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/35575
dc.language.isoeng
dc.publisherSPRINGER HEIDELBERGeng
dc.relation.ispartofEuropean Journal of Nutrition
dc.rightsrestrictedAccesseng
dc.rights.holderCopyright SPRINGER HEIDELBERGeng
dc.subjectChronic beta-alanine supplementationeng
dc.subjectMuscle taurineeng
dc.subjectClinical markerseng
dc.subjectSafetyeng
dc.subjectSide-effectseng
dc.subject.otherskeletal-muscleeng
dc.subject.othercarnosine contenteng
dc.subject.otherindividual fiberseng
dc.subject.otherelderly subjectseng
dc.subject.othersupplementationeng
dc.subject.otherperformanceeng
dc.subject.otherexerciseeng
dc.subject.otherhistidineeng
dc.subject.othercapacityeng
dc.subject.otheranserineeng
dc.subject.wosNutrition & Dieteticseng
dc.title24-Week beta-alanine ingestion does not affect muscle taurine or clinical blood parameters in healthy maleseng
dc.typearticleeng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.affiliation.countryInglaterra
hcfmusp.affiliation.countryisogb
hcfmusp.author.externalFRANCHI, Mariana:Univ Sao Paulo, Fac Med FMUSP, Sch Phys Educ & Sport, Appl Physiol & Nutr Res Grp,Rheumatol Div, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, SP, Brazil
hcfmusp.author.externalSILVA, Vinicius da Eira:Univ Sao Paulo, Fac Med FMUSP, Sch Phys Educ & Sport, Appl Physiol & Nutr Res Grp,Rheumatol Div, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, SP, Brazil
hcfmusp.author.externalPAINELLI, Vitor de Salles:Univ Sao Paulo, Fac Med FMUSP, Sch Phys Educ & Sport, Appl Physiol & Nutr Res Grp,Rheumatol Div, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, SP, Brazil
hcfmusp.author.externalCOSTA, Luiz Augusto Riani:Univ Sao Paulo, Fac Med FMUSP, Sch Phys Educ & Sport, Appl Physiol & Nutr Res Grp,Rheumatol Div, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, SP, Brazil
hcfmusp.author.externalSALE, Craig:Nottingham Trent Univ, Musculoskeletal Physiol Res Grp, Sport Hlth & Performance Enhancement Res Ctr, Nottingham, England
hcfmusp.author.externalHARRIS, Roger Charles:Junipa Ltd, Newmarket, Suffolk, England
hcfmusp.citation.scopus13
hcfmusp.contributor.author-fmusphcBRYAN SAUNDERS
hcfmusp.contributor.author-fmusphcLUANA FARIAS DE OLIVEIRA
hcfmusp.contributor.author-fmusphcRAFAEL PIRES DA SILVA
hcfmusp.contributor.author-fmusphcHAMILTON AUGUSTO ROSCHEL DA SILVA
hcfmusp.contributor.author-fmusphcGUILHERME GIANNINI ARTIOLI
hcfmusp.contributor.author-fmusphcBRUNO GUALANO
hcfmusp.description.beginpage57
hcfmusp.description.endpage65
hcfmusp.description.issue1
hcfmusp.description.volume59
hcfmusp.origemWOS
hcfmusp.origem.pubmed30552505
hcfmusp.origem.scopus2-s2.0-85058392528
hcfmusp.origem.wosWOS:000512078900005
hcfmusp.publisher.cityHEIDELBERGeng
hcfmusp.publisher.countryGERMANYeng
hcfmusp.relation.referenceBAKARDJIEV A, 1994, EUR J BIOCHEM, V225, P617, DOI 10.1111/j.1432-1033.1994.00617.xeng
hcfmusp.relation.referenceBERGSTROM J, 1975, SCAND J CLIN LAB INV, V35, P606, DOI 10.3109/00365517509095787eng
hcfmusp.relation.referenceBlancquaert L, 2017, MED SCI SPORT EXER, V49, P602, DOI 10.1249/MSS.0000000000001213eng
hcfmusp.relation.referenceBlancquaert L, 2016, J PHYSIOL-LONDON, V594, P4849, DOI 10.1113/JP272050eng
hcfmusp.relation.referenceChurch DD, 2017, J AM COLL NUTR, V36, P608, DOI 10.1080/07315724.2017.1335250eng
hcfmusp.relation.referenceCrozier RA, 2007, J NEUROSCI, V27, P4492, DOI 10.1523/JNEUROSCI.4932-06.2007eng
hcfmusp.relation.referenceDawson R, 2002, AMINO ACIDS, V22, P309eng
hcfmusp.relation.referenceDecombaz J, 2012, AMINO ACIDS, V43, P67, DOI 10.1007/s00726-011-1169-7eng
hcfmusp.relation.referencedel Favero S, 2012, AMINO ACIDS, V43, P49, DOI 10.1007/s00726-011-1190-xeng
hcfmusp.relation.referenceDunnett M, 1997, RES VET SCI, V62, P213, DOI 10.1016/S0034-5288(97)90192-2eng
hcfmusp.relation.referenceDunnett M, 1997, J CHROMATOGR B, V688, P47, DOI 10.1016/S0378-4347(97)88054-1eng
hcfmusp.relation.referenceEveraert I, 2013, EUR J APPL PHYSIOL, V113, P1169, DOI 10.1007/s00421-012-2540-4eng
hcfmusp.relation.referenceEveraert I, 2013, MED SCI SPORT EXER, V45, P43, DOI 10.1249/MSS.0b013e31826cdb68eng
hcfmusp.relation.referenceGalloway SDR, 2008, J APPL PHYSIOL, V105, P643, DOI 10.1152/japplphysiol.90525.2008eng
hcfmusp.relation.referenceHamilton EJ, 2006, AMINO ACIDS, V31, P273, DOI 10.1007/s00726-006-0291-4eng
hcfmusp.relation.referenceHarris RC, 1998, J SPORT SCI, V16, P639eng
hcfmusp.relation.referenceHarris RC, 2006, AMINO ACIDS, V30, P279, DOI 10.1007/s00726-006-0299-9eng
hcfmusp.relation.referenceHarris RC, 2010, MED SCI SPORT EXER, V42, P107, DOI 10.1249/01.MSS.0000385977.18201.74eng
hcfmusp.relation.referenceHill CA, 2007, AMINO ACIDS, V32, P225, DOI 10.1007/s00726-006-0364-4eng
hcfmusp.relation.referenceHobson RM, 2012, MED SCI SPORT EXER, V44, P446eng
hcfmusp.relation.referenceIto T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107409eng
hcfmusp.relation.referenceKelly VG, 2017, J SCI MED SPORT, V20, P12, DOI 10.1016/j.jsams.2016.06.006eng
hcfmusp.relation.referenceMaughan RJ, 2018, BRIT J SPORT MED, V52, P439, DOI 10.1136/bjsports-2018-099027eng
hcfmusp.relation.referenceNeves M, 2012, SCAND J MED SCI SPOR, V22, P175, DOI 10.1111/j.1600-0838.2010.01264.xeng
hcfmusp.relation.referenceRipps H, 2012, MOL VIS, V18, P2673eng
hcfmusp.relation.referenceSaunders B, 2017, MED SCI SPORT EXER, V49, P896, DOI 10.1249/MSS.0000000000001173eng
hcfmusp.relation.referenceSaunders B, 2017, BRIT J SPORT MED, V51, P658, DOI 10.1136/bjsports-2016-096396eng
hcfmusp.relation.referenceSaunders B, 2013, J SCI MED SPORT, V16, P286, DOI 10.1016/j.jsams.2012.07.004eng
hcfmusp.relation.referenceSchaffer SW, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-S1-S2eng
hcfmusp.relation.referenceStellingwerff T, 2012, AMINO ACIDS, V42, P2461, DOI 10.1007/s00726-011-1054-4eng
hcfmusp.relation.referenceTallon MJ, 2007, BIOGERONTOLOGY, V8, P129, DOI 10.1007/s10522-006-9038-6eng
hcfmusp.relation.referenceVaranoske AN, 2019, AMINO ACIDS, V51, P49, DOI 10.1007/s00726-018-2609-4eng
hcfmusp.relation.referenceVaranoske AN, 2017, NUTR RES, V48, P16, DOI 10.1016/j.nutres.2017.10.002eng
hcfmusp.relation.referenceWarskulat U, 2004, FASEB J, V18, P577, DOI 10.1096/fj.03-0496fjeeng
hcfmusp.scopus.lastupdate2024-05-10
relation.isAuthorOfPublication39afd5be-de53-43b7-bc2f-24532eec0e43
relation.isAuthorOfPublication4ebc76f6-ffc8-4e43-81a1-a85cc60c561b
relation.isAuthorOfPublicationae931d3d-9e35-450b-84cd-b87d5176838a
relation.isAuthorOfPublicationb7438df7-d183-4a0f-a97f-2d70d38200af
relation.isAuthorOfPublication833cdd9d-bcf7-4352-b10d-d04ff8717cd0
relation.isAuthorOfPublication5c94f430-a9d0-4b0e-b23a-9a9b1fc12a9a
relation.isAuthorOfPublication.latestForDiscovery39afd5be-de53-43b7-bc2f-24532eec0e43
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
art_SAUNDERS_24Week_betaalanine_ingestion_does_not_affect_muscle_taurine_2020.PDF.pdf
Tamanho:
806.17 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)